| 标题 |
Efficacy and safety of second-line treatments in patients with advanced EGFR-mutated non-small cell lung cancer progressing on osimertinib without identified targetable resistance mechanism at progression |
| 网址 | |
| DOI | |
| 其它 |
期刊:Respiratory Medicine and Research 作者:Paul Lajoinie; Vincent Fallet; Marie Wislez; Pauline du Rusquec; Valérie Gounant; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)